Trial Profile
Nesiritide and Vo2 Max in Heart Failure Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jun 2013
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 03 Oct 2006 Status change
- 27 Nov 2005 New trial record.